MPA Business Services
 
 
 
 
 
MPA Business Services Home Our Services Our Clients Resources Contact Us Who We Are
 

Our Services

Pharmaceutical Patent & SPC Expiry Database >

1st EU Marketing Authorisations >

Product Licences >

Parallel Import Certificates >

PCA Data England 2010 >

Tell Us What You Need >

Register With MPA Now >

Client Login >

 

Patent Intelligence Briefings

Pharmaceutical Patents

Supplementary Protection Certificates (SPCs)

Paediatric Extensions

Data & Marketing Exclusivity

Exclusivity vs. Patent Cover

Paediatric Use Marketing Authorisations

The Specific Mechanism

Patents, Trademarks, Copyrights

Product, Process & Formulation Patents

Key Patent Definitions

 

News

Singulair - Sigma Pharmaceuticals Plc vs Merck Sharpe & Dohme

Specific Mechanism – Ambiguity, Confusion and Conflict

Medeva and Georgetown - Combination Drugs and SPCs

 

<< Patent Intelligence Briefings / << Anatomical Classification of Pharmaceutical Products / International Patent Agreements >>

Definition of Key Terms

INN: International Non-Proprietary Name To standardise the identity of individual molecules we use the INN which is known in all countries.

CAS RN: Chemical Abstracts Registry Number unique to the molecule that would allow further investigation other than patents if required.

Anatomical Code: Classification of drugs devised by EPhMRA

Patentee: The applicant

Patent No: Patent number by which the patent specification is identified, designated (11) under identification of Bibliographic Data on Patent Documents (INID). This number is usually preceded by the national designated lettering associated with the country in which the patent applies, i.e. FR=France, DE=Germany, etc.

Filing Date: The date of filing the specification from which the duration is measured according to the law of the country in which the patent is lodged.

EP Patent No. The number attributed to a European filing application. It is not, strictly speaking a single patent but a basked of patents applicable tin the states designated on the specification. The patent laws for each country apply, but the priority date and filings are common to all states.

EP Patent Date: Priority Date: Date which application first submitted Priority Suffix: Country in which the application was first filed.

Expiry Date: Estimated expiry of the patent according to the laws of the country. It is important to observe the national laws as these may signify differences in expiry. For expiry, in the UK duration (20 years) is measured from the date of filing including that day, whereas in Germany the duration starts the day after the filing date. Therefore, German patent duration will always appear to be the day longer than elsewhere. This date is not published in the public records and it estimated.

SPC Expiry: Supplementary Protection Certificate (SPC) is the Pharmaceutical Patent Term Extension allowed under EU Regulation EC 1768/92 which ensures 15 years exclusivity by allowing up to an extra 5 years patent duration. SPC’s are evaluated and granted nationally and the expiry date published when granted.

Country 1st Authorisation: The EU member where the marketing authorisation was first granted and from which the 15 years exclusivity applies.

Licence No. 1st Authorisation: Marketing authorisation identity in the country in which it first was filed. 1st EU

Authorisation Date: Date of first authorisation in the EU member state dictating the 15 (fifteen) years period of exclusivity.

Authorisation Date: Date of authorisation in the country in which the SPC is being filed.

SPC Patent Used: Patent against which the SPC is filed.

SPC Patentee: Applicant of the patent against which the SPC if filed.

SPC Grant Action: Grant, Expired, Revoked, Refused

SPC Expiry Date: Supplementary Protection Certificate (SPC) is the Pharmaceutical Patent Term Extension allowed under EU Regulation EC 1768/92 which ensures 15 years exclusivity by allowing up to an extra 5 years patent duration. SPC’s are evaluated and granted nationally and the expiry date published when granted. Granted or Estimated: G=Grant; E=Estimated

SPC Brand: Brand identified on marketing authorisation cited for the SPC.

 
   
 
 
 
::  News  ::  About Us  ::  Contact Us  ::  Site Map  ::  Terms & Conditions
 
EC Regulation 469/2009 Article 20 EU Supplementary Protection Certificates | Pharmaceutical Patent Term Extensions
Pharmaceutical Patent Intelligence | French Generics Market | UK Parallel Imports and Pharmaceutical Patents
 
© MPA Business Services Limited 2011. All Rights Reserved.